These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34917515)

  • 1. The Role of Decorin and Biglycan Signaling in Tumorigenesis.
    Diehl V; Huber LS; Trebicka J; Wygrecka M; Iozzo RV; Schaefer L
    Front Oncol; 2021; 11():801801. PubMed ID: 34917515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
    Schaefer L; Tredup C; Gubbiotti MA; Iozzo RV
    FEBS J; 2017 Jan; 284(1):10-26. PubMed ID: 27860287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.
    Gubbiotti MA; Buraschi S; Kapoor A; Iozzo RV
    Semin Cancer Biol; 2020 May; 62():1-8. PubMed ID: 31078640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles for small leucine-rich proteoglycans in bone formation.
    Waddington RJ; Roberts HC; Sugars RV; Schönherr E
    Eur Cell Mater; 2003 Oct; 6():12-21; discussion 21. PubMed ID: 14562268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.
    Colon-Caraballo M; Lee N; Nallasamy S; Myers K; Hudson D; Iozzo RV; Mahendroo M
    Matrix Biol; 2022 Jan; 105():53-71. PubMed ID: 34863915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small leucine-rich proteoglycans in kidney disease.
    Schaefer L
    J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological interplay between proteoglycans and their innate immune receptors in inflammation.
    Frey H; Schroeder N; Manon-Jensen T; Iozzo RV; Schaefer L
    FEBS J; 2013 May; 280(10):2165-79. PubMed ID: 23350913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.
    Bi Y; Stuelten CH; Kilts T; Wadhwa S; Iozzo RV; Robey PG; Chen XD; Young MF
    J Biol Chem; 2005 Aug; 280(34):30481-9. PubMed ID: 15964849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.
    Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A
    Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin.
    Nastase MV; Janicova A; Roedig H; Hsieh LT; Wygrecka M; Schaefer L
    J Histochem Cytochem; 2018 Apr; 66(4):261-272. PubMed ID: 29290137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site.
    Monfort J; Tardif G; Reboul P; Mineau F; Roughley P; Pelletier JP; Martel-Pelletier J
    Arthritis Res Ther; 2006; 8(1):R26. PubMed ID: 16507124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva.
    Alimohamad H; Habijanac T; Larjava H; Häkkinen L
    J Periodontal Res; 2005 Feb; 40(1):73-86. PubMed ID: 15613083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin.
    Ward M; Ajuwon KM
    Cell Prolif; 2011 Aug; 44(4):343-51. PubMed ID: 21702857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.
    Moreth K; Iozzo RV; Schaefer L
    Cell Cycle; 2012 Jun; 11(11):2084-91. PubMed ID: 22580469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.
    Schaefer L; Gröne HJ; Raslik I; Robenek H; Ugorcakova J; Budny S; Schaefer RM; Kresse H
    Kidney Int; 2000 Oct; 58(4):1557-68. PubMed ID: 11012890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biglycan-like extracellular matrix genes of agnathans and teleosts.
    Shintani S; Sato A; Toyosawa S; O'hUigin C; Klein J
    J Mol Evol; 2000 Oct; 51(4):363-73. PubMed ID: 11040287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct secondary structures of the leucine-rich repeat proteoglycans decorin and biglycan. Glycosylation-dependent conformational stability.
    Krishnan P; Hocking AM; Scholtz JM; Pace CN; Holik KK; McQuillan DJ
    J Biol Chem; 1999 Apr; 274(16):10945-50. PubMed ID: 10196174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture.
    Kähäri VM; Larjava H; Uitto J
    J Biol Chem; 1991 Jun; 266(16):10608-15. PubMed ID: 2037600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5.
    Svensson L; Heinegård D; Oldberg A
    J Biol Chem; 1995 Sep; 270(35):20712-6. PubMed ID: 7657652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel.
    Boskey AL; Spevak L; Doty SB; Rosenberg L
    Calcif Tissue Int; 1997 Oct; 61(4):298-305. PubMed ID: 9312200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.